A Case for Reviews

Christian Daughton's essay1 rightly criticizes scientists for being insufficiently familiar with research literature. I would extend Daughton's views by emphasizing the value of good review publications. Unfortunately, scientists have little incentive to write reviews, because reviews are typically undervalued by science administrators. Administrators value discovery and apparently do not appreciate the fact that writing a review can take as much or more time, effort, and creativity as doing the

Written byW.r. (bill) Klemm
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Many bench scientists cannot write good reviews, because they do not have the necessary skills in writing, critical thinking, insight, or creativity. The best review papers are often written by senior, experienced people. Such experience brings a breadth and depth of understanding that cannot be acquired in graduate school. Too many young scientists think that the only important science is that which is being done now or no more than a year or so ago.

There seems to be a special role here for older scientists who often do less bench research, because they have been "left behind" by new techniques, new research fads, new-era grant-review panels, or by a bias of grant agencies for young investigators. Older scientists can get "out in front" again by writing reviews, the need for which grows with the growth in primary literature.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies